New textbook describes the latest research results for the treatment of periprosthetic joint infections

• The collected volume provides a clear overview of information about the diagnosis, therapy, prevention and costs of joint infections
• Available as of October 2017

The recently published textbook ‘Management of Periprosthetic Joint Infections’ presents a clear overview of the latest developments and findings in the treatment of periprosthetic infections in hip and knee joints. The authors of the volume are renowned international experts in their particular areas, and in their contributions to the book share their many years of clinical experience using numerous clinical case studies. The editor is Professor Klaus-Dieter Kühn of the Medical University of Graz and Senior Scientific Advisor at Heraeus Medical. ‘The book is intended to encourage doctors to apply the latest findings in the therapy and prevention of periprosthetic infections and thus to continuously improve treatment options and outcomes’, said Kühn.

Professor Klaus-Dieter Kühn sees a considerable need for the collection: ‘The treatment of periprosthetic infections has changed greatly in recent decades. One of the most important developments is that treatment is now administered by an interdisciplinary medical team made up of orthopaedic surgeons, infection specialists, microbiologists, pathologists and – depending on the case – plastic surgeons as well.’ There are also new surgical methods, technologies and materials such as antibiotic-loaded bone cements, e.g., from Heraeus Medical, and antibacterial coatings, as well as procedures for the removal of biofilms, the detection of pathogens and antibiotic resistances, and for diagnostics.

The book is published in English and is available from Springer Verlag Berlin and Heidelberg (ISBN 978-3-662-54468-6) in printed format or as e-book:
https://www.springer.com/de/book/9783662544686

Heraeus Medical is a leader in the area of bone cements and biomaterials for surgical orthopaedics and trauma surgery. This enables the company to make an important contribution to supporting surgeons and the surgical team and to improve surgery outcomes. In the area of biomaterials, Heraeus Medical focuses on products for use in bone and joint surgery. The core product PALACOS® is considered the gold standard among bone cements and has repeatedly proven itself over five decades of clinical use. PALACOS® R+G - the first bone cement with antibiotics for infection prophylaxis in endoprosthetics - was developed over 45 years ago.

Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned company formed in 1851. With expertise, a focus on innovations, operational excellence and an entrepreneurial leadership, we strive to continuously improve the businesses of our customers around the world.
We create high-quality solutions for our customers and strengthen their long-term competitiveness by combining material expertise with technological know-how. Our ideas are focused on important issues such as the environment, energy, health, mobility and industrial applications. Our portfolio ranges from components to coordinated material systems which are used in a wide variety of industries, including the steel, electronics, chemical, automotive and telecommunications industries.In the 2015 financial year, Heraeus generated revenues without precious metals of €1.9 bn and a total revenue of €12.9 bn. With approximately 12,500 employees worldwide in more than 100 subsidiaries in 38 countries, Heraeus holds a leading position in its global markets. In 2016, the Foundation for Family Businesses named Heraeus as one of the “Top 10 Family Businesses” in Germany.

Contact:
Heraeus Medical GmbH
Lilian Winkler
Manager Communication
Philipp-Reis-Str. 8-13
61273 Wehrheim
Tel.: +49 6181-352995
E-Mail: Lilian.Winkler(at)heraeus.com

akampion
Dr. Ludger Wess / Ines-Regina Buth
Managing Partners
info(at)akampion.com
Tel. +49 40 88 16 59 64
Tel. +49 30 23 63 27 68

This release was published on openPR.